Trends in intracranial meningioma incidence in the United States, 2004‐2015.

Background: Meningioma incidence was reported to have risen substantially in the United States during the first decade of the 21st century. There are few reports about subsequent incidence trends. This study provides updated data to investigate trends in meningioma incidence by demographic and tumor characteristics at diagnosis in the United states from 2004 to 2015. Methods: Trends in meningioma incidence were analyzed using data from the Surveillance, Epidemiology, and End Results‐18 (SEER‐18) registry database of the National Cancer Institute. The joinpoint program was used to calculate annual percent change (APC) in incidence rates. Results: The overall incidence of meningioma increased by 4.6% (95% CI, 3.4‐5.9) annually in 2004‐2009, but remained stable from 2009 to 2015 (APC, 0; 95% CI, −0.8 to 0.8). Females (10.66 per 100 000 person‐years) and blacks (9.52 per 100 000 person‐years) had significant predominance in meningioma incidence. Incidence in many subgroups increased significantly up to 2009 and then remained stable until 2015. However, meningioma incidence in young and middle‐aged people increased significantly throughout the entire time period from 2004 to 2015 (APC: 3.6% for <20‐year‐olds; 2.5% for 20‐39‐year‐olds; 1.8% for 40‐59‐year‐olds). The incidence of WHO II meningioma increased during 2011‐2015 (APC = 5.4%), while the incidence of WHO III meningioma decreased during 2004‐2015 (APC = −5.6%). Conclusion: In this study, the incidence of meningioma was found to be stable in recent years. Possible reasons for this finding include changes in population characteristics, the widespread use of diagnostic techniques, and changes in tumor classification and risk factors in the US population. [ABSTRACT FROM AUTHOR]